December 16, 2019 + Jessica Di Palo
7 Min read
The healthcare industry is in the midst of a se a change, inspired by the urgent demand for lower cost, higher quality strategies that improve and extend lives. This has, in turn, fostered growing support for a more sustainable healthcare framework, where incentives are oriented toward prevention and quality of care rather than higher volumes and post-diagnosis treatment.
The healthcare industry is in the midst of a sea change, inspired by the urgent demand for lower cost, higher quality strategies that improve and extend lives. This has, in turn, fostered growing support for a more sustainable healthcare framework, where incentives are oriented toward prevention and quality of care rather than higher volumes and post-diagnosis treatment. Further bolstered by an array of economic, demographic and other factors, as well as major technological advances and converging stakeholder interests, the result has been a broad search for digitally-connected, decentralized and patient-centric solutions. With traditional industry players, technology giants, and private equity and other financial operators rushing to join the fray, the healthtech revolution looks to be an investment opportunity-in-the-making.
SFDR Art. 8 or Art. 9? What’s the difference?
SFDR: getting the terminology right
MTIP participates in Oviva’s new $80m Series C funding
Oviva raises $80 million financing round
MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence
MTIP's new investment in Intelligencia
Private Equity 101: Part one – Glossary
Are you new to the healthtech space?
Leading brands revolutionize care journeys with Lumeon
How Lumeon orchestrates care journey
Trialbee – our hero in patient matching and recruiting for clinical trials
Trialbee - patient matching and recruiting
Digital healthcare: patient-first?
Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital
SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?
New SFDR obligations
MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation
First Closing of Fund II
How to pitch to a healthtech Investor
MTIP invests in Koa Health to make mental health treatment more accessible
New investment in Koa Health
MTIP scored fantastic grades in the UNPRI assessment report of 2020
UNPRI Report grades 2020
4 Health VCs Share Their Business Priorities and What is Next
MTIP invests in Trialbee
New investment in Trialbee
TytoCare closes $50 million round as the demand for telehealth accelerates
TytoCare closes new round
The digital healthtech sector is expanding – and so are we!
Two new empolyees start in April
MTIP has sucessfully exited Blueprint Genetics
Blueprint exit January 2020
New MTIP investment in Oviva
New investment in Oviva
Whitepaper: A positive prognosis for the future of healthtech
Our first Whitepaper
Elite Summit 2019 – Interview with our Managing Partner Christoph Kausch
Elite Summit 2019
MTIP Healthcare Clinic 2019
Healthcare clinic 2019
New MTIP investment in Cynerio
New investment in Cynerio
MTIP invests in Lumeon Ltd.
New investment in Lumeon
Magenverkleinerung mit der Handnähmaschine
Nitinotes news paper article
New MTIP investment in Quanta Dialysis Technologies
New investment in Quanta